Lian Hua Qing Wen: Perannya pada Terapi COVID-19

Authors

  • Marco Vidor Fakultas Kedokteran dan Ilmu Kesehatan, UNIKA Atma Jaya, Jakarta, Indonesia
  • Sherly Lawrensia Fakultas Kedokteran dan Ilmu Kesehatan, UNIKA Atma Jaya, Jakarta, Indonesia

DOI:

https://doi.org/10.55175/cdk.v48i4.68

Keywords:

traditional Chinese medicine, terapi COVID-19, Lian Hua Qing Wen

Abstract

Pandemi COVID-19 belum berakhir. Berbagai studi mengenai terapi COVID-19 masih terus berjalan. Peran Traditional Chinese Medicine (TCM) sebagai salah satu terapi adjuvan COVID-19 masih kontroversial. Lian Hua Qing Wen sebagai salah satu jenis TCM, berpotensi menjadi salah satu adjuvan pada terapi COVID-19.

COVID-19 pandemic is still ravaging. Studies are being conducted to determine the best therapeutic option for COVID-19. The role of Traditional Chinese Medicine (TCM) as an adjuvant therapy for COVID-19 is still controversial. As one of the TCM, Lian Hua Qing Wen may have a role as an adjuvant to COVID-19 treatment.

Downloads

Download data is not yet available.

References

World Health Organization. WHO coronavirus (COVID-19) dashboard [Internet]. Available from: https://covid19.who.int

Li LC, Zhang ZH, Zhou WC, Chen J, Jin HQ, Fang HM, et al. Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects. Biomed Pharmacother. 2020;130:110641.

Wang CH, Zhong Y, Zhang Y, Liu JP, Wang YF, Jia WN, et al. A network analysis of the Chinese medicine Lianhua-Qingwen formula to identify its main effective components. Molecular BioSystems. 2016;12(2):606-13.

BPOM. Cek produk BPOM [Internet]. Available from: https://cekbpom.pom.go.id/index.php/home/produk/erk8qqkquiscpk9f1h5bspsop0/10/row/10/page/0/order/4/DESC/search/0/TI144348471

Komite Penanganan COVID-19 dan Pemulihan Ekonomi Nasional. [Salah] Lianhua Qingwen dapat digunakan sebagai obat COVID-19 [Internet]. 2021 Jan 28. Available from: https://covid19.go.id/p/hoax-buster/salah-lianhua-qingwen-dapat-digunakan-sebagai-obat-covid-19

Zhao P, Yang HZ, Lv HY, Wei ZM. Efficacy of Lianhua qingwen capsule compared with oseltamivir for influenza A virus infection: A meta-analysis of randomized, controlled trials. Altern Ther Health Med. 2014;20(2):25-30.

Niu QQ, Chen Y, Liu Y, Mao SZ, Wang H, Zheng WK, et al. Efficacy and safety of LianhuaQingwen capsule for influenza: A systematic review. ZhongguoZhongyaozazhi=Zhongguozhongyaozazhi= China J Chinese MateriaMedica. 2017;42(8):1474-81.

Yang C, Wang Y, He J, Yan W, Jiang H, Chen Q, et al. Lianhua-Qingwen displays antiviral and anti-inflammatory activity and synergistic effects with oseltamivir against influenza B virus infection in the mouse model. Evid Based Complement Alternat Med. 2020;2020:3196375.

Cul W, Jln X, Zhang Y, Wang H, Yao ML, Qilong HE. Effect of Lianhua qingwen capsules on inflammatory cytokines and junction protein expression in mice with acute lung injury induced by lipopolysaccharides. Chinese J PharmacolToxicol. 2015;2:213-9.

Gao D, Niu M, Wei SZ, Zhang CE, Zhou YF, Yang ZW, et al. Identification of a pharmacological biomarker for the bioassay-based quality control of a thirteencomponent TCM formula (Lianhua Qingwen) used in treating influenza A virus (H1N1) infection. Frontiers in Pharmacology 2020;11:746.

Zhu SY, Li XY, Wei YL, Yang PY, Qin ED. Preliminary study on the inhibitory effect of three traditional Chinese medicine prescriptions on SARS-associated coronavirus in vitro, Lett. Biotechnol. 2003;05:390–2

Xiao M, Tian J, Zhou Y, Xu X, Min X, Lv Y, et al. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial. Pharmacol Res. 2020;161:105126.

Dong L, Xia JW, Gong Y, Chen Z, Yang HH, Zhang J, et al. Effect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease. Evidence-Based Complementary and Alternative Medicine. 2014;2014:637969.

Lv RB, Wang WJ, Li X, Combined with western medicine conventional therapy in the treatment of 63 suspected cases of Coronavirus Disease 2019. J Tradit Chin Med. 2020;61:655–9.

Hu K, Guan WJ, Bi Y, Zhang W, Li L, Zhang B, et al. Efficacy and safety of Lianhua qingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial. Phytomedicine 2020:153242. doi: 10.1016/j.phymed.2020.153242

Zhang X, Cao D, Liu J, Zhang Q, Liu M. Efficacy and safety of Lianhua Qingwen combined with conventional antiviral Western Medicine in the treatment of coronavirus disease (covid-19) in 2019: Protocol for a systematic review and meta-analysis. Medicine 2020;99(30):e21404.

Kementerian Kesehatan Republik Indonesia. Pedoman pencegahan dan pengendalian coronavirus disease (COVID-19) [Internet]. 2020. Available from: https://covid19.kemkes.go.id/protokol-covid-19/kmk-no-hk-01-07-menkes-413-2020-ttg-pedoman-pencegahan-dan-pengendalian-covid-19

Downloads

Published

01-04-2021

How to Cite

Vidor, M., & Lawrensia, S. (2021). Lian Hua Qing Wen: Perannya pada Terapi COVID-19. Cermin Dunia Kedokteran, 48(4), 252–254. https://doi.org/10.55175/cdk.v48i4.68